4 assets in Glycogen Storage Disease Due To Acid Maltase Deficiency, Infantile Onset

Therapeutic assets addressing Glycogen Storage Disease Due To Acid Maltase Deficiency, Infantile Onset, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cipaglucosidase Alfa Glycogen Storage Disease Due To Acid Maltase Deficiency, Infantile Onset	Amicus Therapeutics	P3	B (60)
Miglustat Glycogen Storage Disease Due To Acid Maltase Deficiency, Infantile Onset	Amicus Therapeutics	P3	B (60)
gc301 Glycogen Storage Disease Due To Acid Maltase Deficiency, Infantile Onset	GeneCradle Inc	P1/2	CCC (48)
Iduronidase, .Alpha.-L-(8-Histidine) (Human) Glycogen Storage Disease Due To Acid Maltase Deficiency, Infantile Onset	University of California, San Francisco	P1	CC (43)